< Back to scientific publications

Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 10.49

Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine.

Authors: Ferroni P, Barbanti P, Spila A, Fratangeli F, Aurilia C, Fofi L, Aegean G, Gains F.

Date: 2018

Scope of interest: Biomarkers


Read details
Report/Poster of Convention/Congress Act

New Opportunities in Epilepsy Drug Therapy

Authors: M. Fanella

Date: 2022

Scope of interest: Epilepsy


Read details
Magazine 2,646

Pharmacoeconomics and ageing

Authors: Bustacchini S, Corsonello A, Onder G, Guffanti EE, Marchegiani F, Abbatecola AM, Lattanzio

Date: 2009

Scope of interest: pharmacology, ageing


Read details